Use of Consent Language and Mode to Improve Interactive Voice Response Survey in Colombia and Uganda

NCT04394520 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 3786

Last updated 2020-05-19

No results posted yet for this study

Summary

This study evaluates the effect of one new form of introduction language and three new modes of providing consent on interactive voice response (IVR) survey cooperation, response, refusal and contact rates, as compared to control group, in Colombia and Uganda.

Conditions

  • Surveys and Questionnaires
  • Noncommunicable Diseases

Interventions

OTHER

Modified Introduction

A variation in the introductory content to motivate participants to complete the survey. Participants will be presented with modified introductory language based on the findings from local focus groups and key informant interviews.

OTHER

Active Opt-in

A variation in the consent mode to motivate participants to complete the survey. Participants will be given the choice to actively opt-in to the survey, if they do not respond, the survey will terminate.

OTHER

Active Opt-out

A variation in the consent mode to motivate participants to complete the survey. Participants will be given the choice to actively opt-out to the survey, if they do not respond, the survey will continue.

OTHER

Passive Opt-in

A variation in the consent mode to motivate participants to complete the survey. Participants will be given the choice to passively opt-in to the survey, if they do not hang-up, the survey will continue.

Sponsors & Collaborators

  • The Bloomberg Family Foundation, Inc.

    collaborator OTHER
  • Makerere University

    collaborator OTHER
  • Pontificia Universidad Javeriana

    collaborator OTHER
  • Johns Hopkins Bloomberg School of Public Health

    lead OTHER

Principal Investigators

  • Adnan A Hyder, PhD, MBBS · Johns Hopkins University Bloomberg School of Public Health

  • George W. Pariyo, PhD · Johns Hopkins University Bloomberg School of Public Health

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-08-31
Primary Completion
2019-01-05
Completion
2019-01-05

Countries

  • Colombia
  • Uganda

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04394520 on ClinicalTrials.gov